<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">JOP</journal-id>
<journal-id journal-id-type="hwp">spjop</journal-id>
<journal-id journal-id-type="nlm-ta">J Psychopharmacol</journal-id>
<journal-title>Journal of Psychopharmacology</journal-title>
<issn pub-type="ppub">0269-8811</issn>
<issn pub-type="epub">1461-7285</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0269881113477746</article-id>
<article-id pub-id-type="publisher-id">10.1177_0269881113477746</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Papers</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>First episode psychosis patients show impaired cognitive function – a study of a South Asian population in the UK</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Saleem</surname><given-names>Majid M</given-names></name>
<xref ref-type="aff" rid="aff1-0269881113477746">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Harte</surname><given-names>Michael K</given-names></name>
<xref ref-type="aff" rid="aff2-0269881113477746">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Marshall</surname><given-names>Kay M</given-names></name>
<xref ref-type="aff" rid="aff2-0269881113477746">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Scally</surname><given-names>Andy</given-names></name>
<xref ref-type="aff" rid="aff3-0269881113477746">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Brewin</surname><given-names>Anita</given-names></name>
<xref ref-type="aff" rid="aff4-0269881113477746">4</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Neill</surname><given-names>Jo C</given-names></name>
<xref ref-type="aff" rid="aff2-0269881113477746">2</xref>
</contrib>
</contrib-group>
<aff id="aff1-0269881113477746"><label>1</label>Centre for Mental Health Research and Education, Calgary, Canada</aff>
<aff id="aff2-0269881113477746"><label>2</label>School of Pharmacy and Pharmaceutical Sciences, University of Manchester, Manchester, UK</aff>
<aff id="aff3-0269881113477746"><label>3</label>School of Health, University of Bradford, Bradford, UK</aff>
<aff id="aff4-0269881113477746"><label>4</label>Bradford Early Intervention Service, Bradford, UK</aff>
<author-notes>
<corresp id="corresp1-0269881113477746">Jo Neill, School of Pharmacy and Pharmaceutical Sciences, University of Manchester, Stopford Building, Oxford Rd, Manchester, M13 9PT, UK. Email: <email>joanna.neill@manchester.ac.uk</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>4</month>
<year>2013</year>
</pub-date>
<volume>27</volume>
<issue>4</issue>
<fpage>366</fpage>
<lpage>373</lpage>
<permissions>
<copyright-statement>© The Author(s) 2013</copyright-statement>
<copyright-year>2013</copyright-year>
<copyright-holder content-type="sage">British Association for Psychopharmacology</copyright-holder>
</permissions>
<abstract>
<sec id="section1-0269881113477746">
<title>Background:</title>
<p>Cognitive deficits are a core symptom of schizophrenia, severely debilitating and untreated by current medication. However, to date there is limited research focusing on the precise nature of the cognitive disturbances at first episode in ethnic populations. Improved understanding of this will allow improved approaches to therapy. The aim of this study was to investigate cognitive function with a first episode of psychosis South Asian patients.</p>
</sec>
<sec id="section2-0269881113477746">
<title>Methods:</title>
<p>Twenty South Asian first episode psychosis patients and 15 healthy South Asian matched controls were recruited. All were second generation South Asian people living in the UK. Subjects who took part in the study completed the Positive and Negative Syndrome Scale (patient group), the Wechsler Test of Adult Reading and a battery of neuropsychological assessments to assess specific domains of cognition of relevance to Measurement and Treatment Research to Improve Cognition in Schizophrenia using the Cambridge Neuropsychological Test Automated Battery (CANTAB) (all groups).</p>
</sec>
<sec id="section3-0269881113477746">
<title>Results:</title>
<p>Results show that first episode patients performed significantly worse than controls across all cognitive domains tested using CANTAB. Significant impairments were found in tests of visual and spatial memory, executive function, working memory, spatial planning and attention. Importantly, a number of cognitive performance indices (visual memory, spatial memory, executive function) were positively correlated with the severity of negative symptoms.</p>
</sec>
<sec id="section4-0269881113477746">
<title>Conclusion:</title>
<p>We demonstrate that first episode South Asian patients display significant and specific cognitive deficits with evidence to support an association between negative symptoms and certain cognitive domains at first episode in this patient population.</p>
</sec>
</abstract>
<kwd-group>
<kwd>First episode psychosis</kwd>
<kwd>cognitive domains</kwd>
<kwd>schizophrenia</kwd>
<kwd>South Asian</kwd>
<kwd>ethnicity</kwd>
<kwd>CANTAB</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section5-0269881113477746" sec-type="intro">
<title>Introduction</title>
<p>Cognitive deficits are recognized as a core feature of schizophrenia (<xref ref-type="bibr" rid="bibr11-0269881113477746">Bozikas and Andreou, 2011</xref>; <xref ref-type="bibr" rid="bibr36-0269881113477746">Heinrichs and Zakzanis, 1998</xref>; <xref ref-type="bibr" rid="bibr55-0269881113477746">Mesholam-Gately et al., 2009</xref>), with patients demonstrating significant impairments in several domains, compared with both psychiatric and non-psychiatric populations (<xref ref-type="bibr" rid="bibr4-0269881113477746">Altshuler et al., 2004</xref>; <xref ref-type="bibr" rid="bibr29-0269881113477746">Gopin et al., 2011</xref>). Research has also shown that first episode psychosis patients show significant cognitive impairments (<xref ref-type="bibr" rid="bibr10-0269881113477746">Bilder et al., 2000</xref>; <xref ref-type="bibr" rid="bibr56-0269881113477746">Mohamed et al., 1999</xref>; <xref ref-type="bibr" rid="bibr59-0269881113477746">Nuechterlein et al., 2011</xref>; <xref ref-type="bibr" rid="bibr69-0269881113477746">Townsend et al., 2001</xref>) and that cognitive deficits are present during the period of clinical high risk of psychosis (<xref ref-type="bibr" rid="bibr7-0269881113477746">Barbato et al, 2012</xref>; <xref ref-type="bibr" rid="bibr15-0269881113477746">Cannon et al., 2000</xref>; <xref ref-type="bibr" rid="bibr22-0269881113477746">Cornblatt, 2002</xref>. <xref ref-type="bibr" rid="bibr28-0269881113477746">Frommann et al., 2011</xref>) and in unaffected siblings (<xref ref-type="bibr" rid="bibr32-0269881113477746">Habets et al., 2008</xref>; <xref ref-type="bibr" rid="bibr46-0269881113477746">Kuha et al., 2007</xref>; <xref ref-type="bibr" rid="bibr57-0269881113477746">Mulet et al., 2007</xref>; <xref ref-type="bibr" rid="bibr72-0269881113477746">Weickert et al., 2010</xref>). There is also evidence to support a consistent relationship between negative symptoms and cognitive impairment in first episode psychosis (<xref ref-type="bibr" rid="bibr5-0269881113477746">Ayres et al., 2007</xref>; <xref ref-type="bibr" rid="bibr30-0269881113477746">Grant and Beck, 2009</xref>). It has previously been demonstrated that negative and cognitive symptoms in psychosis share many characteristics, with similarities in their prevalence, course, prognostic importance and correlations with various aspects of everyday social and occupational functional skills (<xref ref-type="bibr" rid="bibr1-0269881113477746">Addington and Addington, 1999</xref>; <xref ref-type="bibr" rid="bibr2-0269881113477746">Allott et al., 2011</xref>; <xref ref-type="bibr" rid="bibr24-0269881113477746">Faber et al., 2011</xref>; <xref ref-type="bibr" rid="bibr35-0269881113477746">Harvey et al., 2006</xref>; <xref ref-type="bibr" rid="bibr52-0269881113477746">McGurk and Meltzer, 2000</xref>).</p>
<p>However, current antipsychotic medications have not demonstrated efficacy relative to either negative symptoms or cognitive impairment, therefore posing a great unmet clinical need which clearly requires considerable investment and further investigation (<xref ref-type="bibr" rid="bibr24-0269881113477746">Faber et al., 2011</xref>; <xref ref-type="bibr" rid="bibr34-0269881113477746">Harvey and Keefe, 2001</xref>; <xref ref-type="bibr" rid="bibr73-0269881113477746">Weinberger and Gallhofer, 1997</xref>). Improved cognition is considered to be so vital for patient wellbeing that the US National Institute of Mental Health (NIMH) sponsored several initiatives in response to this unmet clinical need, including the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) (<xref ref-type="bibr" rid="bibr53-0269881113477746">Marder, 2006</xref>; <xref ref-type="bibr" rid="bibr54-0269881113477746">Marder and Fenton, 2004</xref>), the Treatment Units for Research on Neurocognition in Schizophrenia (TURNS) (<xref ref-type="bibr" rid="bibr14-0269881113477746">Buchanan et al., 2007</xref>) and the Cognitive Neuroscience Treatment to Improve Cognition in Schizophrenia (CNTRICS) (<xref ref-type="bibr" rid="bibr17-0269881113477746">Carter and Barch, 2007</xref>). The overall objective of these initiatives was to develop novel cognitive enhancers in order to improve the quality of life for patients.</p>
<p>Research has consistently found that there is an increased rate of schizophrenia among migrant and Black and minority ethnic (BME) communities in comparison with other groups, (<xref ref-type="bibr" rid="bibr16-0269881113477746">Cantor-Graae and Selten, 2005</xref>; <xref ref-type="bibr" rid="bibr21-0269881113477746">Coid et al., 2008</xref>; <xref ref-type="bibr" rid="bibr44-0269881113477746">Kirkbride et al., 2008</xref>; <xref ref-type="bibr" rid="bibr51-0269881113477746">McGrath et al., 2004</xref>). In the UK the rate of psychotic disorders in immigrant groups varies with ethnicity (<xref ref-type="bibr" rid="bibr26-0269881113477746">Fearon et al., 2006</xref>; <xref ref-type="bibr" rid="bibr33-0269881113477746">Harrison et al., 1988</xref>) with those from Black African and Black Caribbean heritage having the highest incidence rates and there also being elevated rates of a lesser magnitude in other BME communities (particularly South Asian) (<xref ref-type="bibr" rid="bibr9-0269881113477746">Bhugra et al., 1997</xref>; <xref ref-type="bibr" rid="bibr26-0269881113477746">Fearon et al., 2006</xref>; <xref ref-type="bibr" rid="bibr67-0269881113477746">Singh and Burns, 2006</xref>). There is also evidence to suggest that both first and second generation immigrants are at elevated risk for developing psychosis (<xref ref-type="bibr" rid="bibr21-0269881113477746">Coid et al., 2008</xref>). Studies focusing on BME migrant groups in Bradford, West Yorkshire, UK, which is where the present study was conducted, have reported a higher prevalence of psychosis amongst second generation South Asian people compared with groups of other ethnic origins (<xref ref-type="bibr" rid="bibr12-0269881113477746">Bradford City Strategy, 2008</xref>). However, despite this higher prevalence there is no reported research investigating cognitive function in first episode South Asian patients in the UK. This area of research could be of particular importance as it allows us to examine any differences between cognitive function in South Asian patients living in the UK and findings in other racial groups. If similar deficits are found we may be able to speculate that the severity of cognitive deficits is universal in patients with psychosis regardless of cultural background and ethnicity. What little research has been conducted in this area has investigated cognitive dysfunction in chronic schizophrenia South Asian patients in India (<xref ref-type="bibr" rid="bibr45-0269881113477746">Krishnadas et al., 2007</xref>; <xref ref-type="bibr" rid="bibr50-0269881113477746">McCreadie et al., 1997</xref>). Although this previous research provides a valuable insight into the cognitive function of South Asian patients in India, these findings are not generalizable to first episode South Asian patients living in the UK. In both of these studies, the patients were significantly older and had been suffering from a longer duration of illness than the current sample. In the <xref ref-type="bibr" rid="bibr45-0269881113477746">Krishnadas et al. (2007)</xref> study 88% of the sample was prescribed a first generation antipsychotic and there was a significant amount of poly-pharmacy, which is known to have an adverse effect on cognition. Furthermore, due to the geographical location of these studies, it could be argued that the role of various socio-cultural variables such as social and family support could potentially influence the findings, thus affecting their generalizability.</p>
<p>In the current study we used the Cambridge Neuropsychological Test Automated Battery (CANTAB) to assess cognitive function in a carefully selected group of South Asian first episode patients. One advantage of using CANTAB is that it has been shown to highlight deficits in a broad range of cognitive domains in patients with psychosis and schizophrenia (<xref ref-type="bibr" rid="bibr8-0269881113477746">Barnett et al., 2005</xref>; <xref ref-type="bibr" rid="bibr25-0269881113477746">Fagerlund et al., 2006</xref>; <xref ref-type="bibr" rid="bibr37-0269881113477746">Huddy et al., 2007</xref>; <xref ref-type="bibr" rid="bibr47-0269881113477746">Levaux et al., 2007</xref>). Other advantages are that it is a standardized testing procedure, it has unique ease of use qualities through the use of the touch screen monitor, responses are automatically recorded thus eliminating rater subjectivity and it is culturally unbiased, which is important in testing BME populations (<xref ref-type="bibr" rid="bibr47-0269881113477746">Levaux et al., 2007</xref>). The findings from CANTAB in these previous studies are similar to those found with some traditional neuropsychological tests (MATRICS) (<xref ref-type="bibr" rid="bibr47-0269881113477746">Levaux et al., 2007</xref>).</p>
<p>The aim of the current study was to investigate cognitive function in the specific domains of memory, executive function, planning and attention in first episode second generation South Asian patients and to compare this with cognitive function in a carefully matched South Asian healthy control group.</p>
</sec>
<sec id="section6-0269881113477746" sec-type="methods">
<title>Methods</title>
<sec id="section7-0269881113477746">
<title>Subjects</title>
<p>A total of 20 first episode psychosis patients and 15 healthy South Asian controls were recruited into the study. All participants gave informed written consent. All procedures were approved by a local NHS Research and Ethics Committee along with research and development approval from the West Yorkshire Mental Health Consortium.</p>
<p>The first episode psychosis patients were recruited from the Bradford and Airedale Early Intervention Service. This service provides care to patients aged from 18 to 35 years, living within the Bradford District area (City, South, West and Airedale) within three years of the diagnosis of a psychotic illness. All patients were aged between 22 and 36 and were of South Asian origin. At the start of the study all patients were on antipsychotic medication, 17 were on a second generation antipsychotic (eight on olanzapine (5–10mg), six on risperidone (1–3mg), two on aripiprazole (10mg) and one on amisulpiride (400mg)) and three were on a first generation antipsychotic (pipothiazine depot injection 50mg–75mg). Patients were not on any other form of medication, that is, SSRIs, anticholinergics or anticonvulsants.</p>
<p>Diagnoses of psychotic disorders (schizophrenia, paranoid schizophrenia, psychotic disorder) were determined by a psychiatrist using the Structured Interview for DSM-IV Axis I Disorders (SCID-I; <xref ref-type="bibr" rid="bibr27-0269881113477746">First et al., 1998</xref>) and augmented by discussions with family members and a review of clinical notes. The severity of clinical symptoms was assessed in the patient group using the Positive and Negative Syndrome Scale (PANSS; <xref ref-type="bibr" rid="bibr41-0269881113477746">Kay et al., 1987</xref>). The sequential stability of PANSS has been demonstrated in a number of psychiatric populations (<xref ref-type="bibr" rid="bibr40-0269881113477746">Kay and Singh, 1989</xref>; <xref ref-type="bibr" rid="bibr41-0269881113477746">Kay et al, 1987</xref>; <xref ref-type="bibr" rid="bibr48-0269881113477746">Lindenmayer, 1984</xref>) and the inter-rater reliability has been shown to be highly concordant, with average correlations ranging from 0.83 to 0.87 reported for the positive, negative and general psychopathology scales (<xref ref-type="bibr" rid="bibr43-0269881113477746">Kay et al., 1989</xref>) <xref ref-type="bibr" rid="bibr43-0269881113477746">Kay SR, Opler LA, Lindenmayer JP (1989)</xref>. The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation. Br J Psychiatry 155 (suppl. 7) 59–65. Extensive research has shown that the PANSS is well validated and demonstrates support for the utility of the tool for its specified purposes (<xref ref-type="bibr" rid="bibr39-0269881113477746">Kay and Opler, 1987</xref>; <xref ref-type="bibr" rid="bibr40-0269881113477746">Kay and Singh 1989</xref>; <xref ref-type="bibr" rid="bibr43-0269881113477746">Kay et al., 1989</xref>; <xref ref-type="bibr" rid="bibr42-0269881113477746">1986</xref>; <xref ref-type="bibr" rid="bibr48-0269881113477746">Lindenmayer et al., 1984</xref>).</p>
<p>Inclusion criteria included patients with only a first episode in psychosis as determined by the number of episodes that a patient has had (no more than one). All patients were stabilized on antipsychotic medication, had been part of the Early Intervention in Psychosis service (EIP) service for a minimum of three months and had to be second generation South Asian. Patients were approached at their respective clinics by care co-ordinators and the first author (MMS) in order to introduce the study and obtain consent. Patients were excluded from the study if they were unable to speak English, had a history of any other psychiatric disorders, learning difficulty, severe head injuries or other neurological illnesses or an excessive history of drug or alcohol abuse (either a current diagnosis of any substance abuse or dependence).</p>
<p>The control subjects were recruited from the same catchment areas as the patients by advertising through local community and resource centers. The control group were aged between 19 and 33 years and matched as closely as possible in terms of demographics, race and IQ to the patient group (see <xref ref-type="table" rid="table1-0269881113477746">Table 1</xref>). For the control group, participants were excluded according to the same criteria as patients and if they had a Mini Mental State Examination (MMSE; <xref ref-type="bibr" rid="bibr20-0269881113477746">Cockrell and Folstein, 1998</xref>) score of ≥ 23.</p>
<table-wrap id="table1-0269881113477746" position="float">
<label>Table 1.</label>
<caption>
<p>Demographic data, IQ scores and PANSS scores for control and patient groups.</p>
</caption>
<graphic alternate-form-of="table1-0269881113477746" xlink:href="10.1177_0269881113477746-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Group</th>
<th align="left">Age (years)</th>
<th align="left">Gender (m/f)</th>
<th align="left">Education (years)</th>
<th align="left">WTAR</th>
<th align="left">Total positive symptoms</th>
<th align="left">Total negative symptoms</th>
<th align="left">Total general symptoms</th>
<th align="left">Atypical antipsychotic</th>
<th align="left">Typical antipsychotic</th>
</tr>
<tr>
<th/>
<th align="left">Mean (SD)</th>
<th/>
<th align="left">Mean (SD)</th>
<th align="left">Mean (SD)</th>
<th align="left">Mean (SD)</th>
<th align="left">Mean (SD)</th>
<th align="left">Mean (SD)</th>
<th align="left"><italic>N</italic> (%)</th>
<th align="left"><italic>N</italic> (%)</th>
</tr>
</thead>
<tbody>
<tr>
<td>Control</td>
<td>23.8 (5.2)</td>
<td>12/3</td>
<td>12.4 (1.6)</td>
<td>98.1 (15.3)</td>
<td>–</td>
<td>–</td>
<td>–</td>
<td>–</td>
<td>–</td>
</tr>
<tr>
<td>Patient</td>
<td>26.5 (4.3)</td>
<td>16/4</td>
<td>11.9 (1.8)</td>
<td>94.7 (13.3)</td>
<td>12.1 (1.9)</td>
<td>17.0 (4.3)</td>
<td>28.2 (5.2)</td>
<td>17 (85%)</td>
<td>3(15%)</td>
</tr>
<tr>
<td><italic>p</italic> value</td>
<td>NS</td>
<td>–</td>
<td>NS</td>
<td>NS</td>
<td>–</td>
<td>–</td>
<td>–</td>
<td>–</td>
<td>–</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0269881113477746">
<p>Demographic data and PANSS scores for control (<italic>n</italic>=15) and patient (<italic>n</italic>=20) groups. Values are shown as mean, standard deviation (SD).</p>
</fn>
<fn id="table-fn2-0269881113477746">
<p>M: male; F: female; WTAR: Wechsler Test of Adult Reading; PANSS: Positive and Negative Syndrome Scale; NS: non-significant.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section8-0269881113477746">
<title>Neuropsychological assessment</title>
<p>All subjects who took part in the study completed a comprehensive battery of neuropsychological tests from CANTAB (see <xref ref-type="table" rid="table2-0269881113477746">Table 2</xref>).</p>
<table-wrap id="table2-0269881113477746" position="float">
<label>Table 2.</label>
<caption>
<p>The battery of neuropsychological tests from the Cambridge Neuropsychological Test Automated Battery (CANTAB).</p>
</caption>
<graphic alternate-form-of="table2-0269881113477746" xlink:href="10.1177_0269881113477746-table2.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th align="left">Cognitive domain</th>
<th align="left">CANTAB test</th>
</tr>
</thead>
<tbody>
<tr>
<td>Visual memory</td>
<td>Pattern Recognition Memory (PRM)</td>
</tr>
<tr>
<td>Spatial memory</td>
<td>Spatial Recognition Memory (SRM)</td>
</tr>
<tr>
<td>Executive function</td>
<td>Intra/Extra Dimensional Set Shift (IED)</td>
</tr>
<tr>
<td>Working memory</td>
<td>Stocking of Cambridge (SOC)</td>
</tr>
<tr>
<td>Spatial planning</td>
<td>Stocking of Cambridge (SOC)</td>
</tr>
<tr>
<td>Attention</td>
<td>Choice Reaction Time (CRT)</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>The Wechsler Test of Adult Reading (WTAR; <xref ref-type="bibr" rid="bibr71-0269881113477746">Wechsler, 1997</xref>) was administered to all participants in the study to measure their pre-morbid IQ. All of these tests were administered and results scored by a trained psychologist. All assessments were undertaken on the same day by the same trained psychologist.</p>
<sec id="section9-0269881113477746">
<title>Visual and spatial memory</title>
<p>Visual memory was assessed using the Pattern Recognition Memory (PRM) test. This is a test in which a two-choice forced discrimination paradigm is used. Spatial memory was assessed using the Spatial Recognition Memory (SRM) test, again a two-choice forced discrimination paradigm is used.</p>
<p>Both of these tests have three outcome measures, including the number and percentage of correct trials and speed of subject’s response (<xref ref-type="bibr" rid="bibr65-0269881113477746">Sahakian et al., 1988</xref>).</p>
</sec>
<sec id="section10-0269881113477746">
<title>Executive function</title>
<p>Executive function was assessed using the Intra/Extra Dimensional Set Shift (IED). The IED is a measure of rule acquisition and reversal which includes visual discrimination, attentional set formation, maintenance, shifting and flexibility of attention (<xref ref-type="bibr" rid="bibr60-0269881113477746">Owen et al., 1990</xref>).</p>
</sec>
<sec id="section11-0269881113477746">
<title>Working memory and spatial planning</title>
<p>Working memory and spatial planning were assessed using the Stockings of Cambridge (SOC) test. This is a computerized version of the Tower of London test (<xref ref-type="bibr" rid="bibr66-0269881113477746">Shallice, 1982</xref>). In this test, subjects are required to solve problems in the minimum number of moves. We report results from problems with a minimum of five moves to complete the task.</p>
</sec>
<sec id="section12-0269881113477746">
<title>Attention</title>
<p>Attention was assessed using the Choice Reaction Time (CRT) test. This test is a two-choice reaction time test used to assess general alertness and motor speed (<xref ref-type="bibr" rid="bibr64-0269881113477746">Sahakian and Owen, 1992</xref>).</p>
<p>The reasons for choosing these particular tests from the CANTAB battery were that all of the domains described (memory, executive function, planning and attention) have been shown to be affected in patients with schizophrenia; however, to our knowledge we are the first group to use this particular bespoke battery to assess deficits in these specific domains.</p>
</sec>
</sec>
<sec id="section13-0269881113477746">
<title>Statistical analysis</title>
<p>Data were analyzed using Statistical Package for Social Sciences (SPSS) version 16. Data were assessed for normal distribution using the Kolmogorov–Smirnov test. Comparisons between patients and controls on demographic variables (age, gender, years in education), pre-morbid IQ (WTAR standard scores) and neuropsychological performance were carried out using independent sample <italic>t</italic>-tests comparing the means and standard deviations. A multiple linear regression model analysis was performed using neuropsychological indices and patient symptomatology to examine any predictive relationships. Positive, negative and general symptoms were used as independent variables with scores on the different outcome measures from the CANTAB tests as dependent variables.</p>
</sec>
</sec>
<sec id="section14-0269881113477746" sec-type="results">
<title>Results</title>
<sec id="section15-0269881113477746">
<title>Demographics</title>
<p>As depicted in <xref ref-type="table" rid="table1-0269881113477746">Table 1</xref>, there were no significant differences between the two groups for any of the demographic variables tested: age, gender, education and pre-morbid IQ scores.</p>
</sec>
<sec id="section16-0269881113477746">
<title>Neuropsychological assessments</title>
<sec id="section17-0269881113477746">
<title>PRM</title>
<p>Results from the PRM test demonstrated significant deficits in the patient group compared with the control group across all of the outcome measures. Patients performed significantly worse in this test, as measured by the number of correct responses (<italic>p</italic>&lt;0.001), percent correct responses (<italic>p</italic>&lt;0.001) and mean correct latency (<italic>p</italic>&lt;0.05) compared with controls (see <xref ref-type="table" rid="table3-0269881113477746">Table 3</xref>).</p>
<table-wrap id="table3-0269881113477746" position="float">
<label>Table 3.</label>
<caption>
<p>Comparison of neuropsychological results between patients and healthy controls on CANTAB.</p>
</caption>
<graphic alternate-form-of="table3-0269881113477746" xlink:href="10.1177_0269881113477746-table3.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Cognitive measure</th>
<th align="left">Patients Mean (SD)</th>
<th align="left">Control Mean (SD)</th>
<th align="left"><italic>t</italic></th>
<th align="left"><italic>p</italic> value</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="5"><bold><underline>Visual and spatial memory</underline></bold></td>
</tr>
<tr>
<td><bold>PRM:</bold></td>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td>Number correct</td>
<td>19.7 (2.1)</td>
<td>22.6 (1.7)</td>
<td>14.2</td>
<td>&lt;0.001<xref ref-type="table-fn" rid="table-fn3-0269881113477746">***</xref></td>
</tr>
<tr>
<td>Percent correct</td>
<td>82.1 (8.8)</td>
<td>92.7 (7.4)</td>
<td>4.2</td>
<td>&lt;0.001<xref ref-type="table-fn" rid="table-fn3-0269881113477746">***</xref></td>
</tr>
<tr>
<td>Mean correct latency</td>
<td>23.2 (6.9)</td>
<td>18.7 (2.6)</td>
<td>5.8</td>
<td>&lt;0.05<xref ref-type="table-fn" rid="table-fn3-0269881113477746">*</xref></td>
</tr>
<tr>
<td><bold>SRM:</bold></td>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td>Number correct</td>
<td>15.4 (2.3)</td>
<td>17 (2.3)</td>
<td>4.2</td>
<td>&lt;0.05<xref ref-type="table-fn" rid="table-fn3-0269881113477746">*</xref></td>
</tr>
<tr>
<td>Percent correct</td>
<td>77 (11.5)</td>
<td>85 (11.3)</td>
<td>4.2</td>
<td>&lt;0.05<xref ref-type="table-fn" rid="table-fn3-0269881113477746">*</xref></td>
</tr>
<tr>
<td>Mean correct latency</td>
<td>19.5 (5)</td>
<td>18.8 (4.5)</td>
<td>0.2</td>
<td>NS</td>
</tr>
<tr>
<td><bold><underline>Executive function</underline></bold></td>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td><bold>IED:</bold></td>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td>Pre-ED errors</td>
<td>7.1 (7.6)</td>
<td>4.9 (1.2)</td>
<td>1.2</td>
<td>NS</td>
</tr>
<tr>
<td>EDS errors</td>
<td>17.1 (10.9)</td>
<td>5.9 (1.2)</td>
<td>11.8</td>
<td>&lt;0.01<xref ref-type="table-fn" rid="table-fn3-0269881113477746">**</xref></td>
</tr>
<tr>
<td>Total errors</td>
<td>29.3 (14.2)</td>
<td>10.6 (7.1)</td>
<td>20.5</td>
<td>&lt;0.001<xref ref-type="table-fn" rid="table-fn3-0269881113477746">***</xref></td>
</tr>
<tr>
<td><bold><underline>Working memory and planning</underline></bold></td>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td><bold>SOC:</bold></td>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td>Mean moves (five-move problems)</td>
<td>8.3 (1.7)</td>
<td>6.5 (1.2)</td>
<td>11.8</td>
<td>&lt;0.01<xref ref-type="table-fn" rid="table-fn3-0269881113477746">**</xref></td>
</tr>
<tr>
<td>Mean initial thinking time (five-move problems)</td>
<td>4.2 (6.7)</td>
<td>5.1 ( 3.6)</td>
<td>0.2</td>
<td>NS</td>
</tr>
<tr>
<td>Mean subsequent thinking time (five-move problems)</td>
<td>2.5 ± 3.9</td>
<td>0.9 (1.4)</td>
<td>2.4</td>
<td>NS</td>
</tr>
<tr>
<td>Problems solved in minimum moves</td>
<td>6.50 ± 0.40</td>
<td>8.7 (0.5)</td>
<td>12.5</td>
<td>&lt;0.001<xref ref-type="table-fn" rid="table-fn3-0269881113477746">***</xref></td>
</tr>
<tr>
<td><bold><underline>Attention</underline></bold></td>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td>CRT:</td>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td>Total correct</td>
<td>96.7 (5)</td>
<td>99.4 (0.7)</td>
<td>4.5</td>
<td>&lt;0.05<xref ref-type="table-fn" rid="table-fn3-0269881113477746">*</xref></td>
</tr>
<tr>
<td>Percent correct</td>
<td>96.5 (5)</td>
<td>99.4 (0.7)</td>
<td>4.1</td>
<td>&lt;0.05<xref ref-type="table-fn" rid="table-fn3-0269881113477746">*</xref></td>
</tr>
<tr>
<td>Mean correct latency</td>
<td>4 (1.1)</td>
<td>3.2 ( 9.1)</td>
<td>5.6</td>
<td>&lt;0.05<xref ref-type="table-fn" rid="table-fn3-0269881113477746">*</xref></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn3-0269881113477746">
<label>*</label>
<p><italic>p</italic>&lt;0.05, **<italic>p</italic>&lt;0.01, ***<italic>p</italic>&lt;0.001 <italic>vs</italic>. control.</p>
</fn>
<fn id="table-fn4-0269881113477746">
<p>SD: Standard deviation; IED: Intra/Extra Dimensional Set Shift; ED: Extra Dimensional; EDS: Extra Dimensional Shift; SOC: Stockings of Cambridge; PRM: Pattern Recognition Memory; SRM: Spatial Recognition Memory; CRT: Choice Reaction Time.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section18-0269881113477746">
<title>SRM</title>
<p>Results from the SRM test demonstrated significant deficits in the patient group compared with the control group across two of the three outcome measures. Patients scored significantly lower in the number of correct responses (<italic>p</italic>&lt;0.05) and percent correct responses (<italic>p</italic>&lt;0.05) compared with controls. There was no significant difference in mean correct latency between patients and controls (see <xref ref-type="table" rid="table3-0269881113477746">Table 3</xref>).</p>
</sec>
<sec id="section19-0269881113477746">
<title>IED</title>
<p>Results from the IED test demonstrated significant deficits in the patient group compared with the control group across two of the three outcome measures. Patients showed a significant increase in both extra-dimensional shift errors (<italic>p</italic>&lt;0.01) and total errors (<italic>p</italic>&lt;0.001) compared with controls. However, in the pre extra-dimensional shift errors stage, although patients showed an increase in the number of errors made, there was no statistically significant difference between the two groups (see <xref ref-type="table" rid="table3-0269881113477746">Table 3</xref>).</p>
</sec>
<sec id="section20-0269881113477746">
<title>SOC</title>
<p>Results demonstrated significant deficits in the patient group compared with the control group in working memory and planning in the SOC task. There was a significant difference (<italic>p</italic>&lt;0.01) in the mean number of moves taken to complete a problem, with patients taking more moves than controls. Patients were also significantly impaired (<italic>p</italic>&lt;0.001) in the problems solved in minimum moves measure compared with the control group. Mean initial thinking time and mean subsequent thinking time were both increased in the patient group; however, these effects did not reach statistical significance (see <xref ref-type="table" rid="table3-0269881113477746">Table 3</xref>).</p>
</sec>
<sec id="section21-0269881113477746">
<title>CRT</title>
<p>Results for CRT showed significant deficits across all three outcome measures in patients compared with controls. Patients had significantly lower (<italic>p</italic>&lt;0.05) total and percent correct scores and significantly higher (<italic>p</italic>&lt;0.05) mean correct latency scores (from stimulus appearance to button press) in this test (see <xref ref-type="table" rid="table3-0269881113477746">Table 3</xref>).</p>
</sec>
</sec>
<sec id="section22-0269881113477746">
<title>Relation between psychiatric symptoms and cognitive performance</title>
<p>In the linear regression analysis, in the patient group only, comparing symptom scores (PANSS) and neuropsychological performance there were no significant associations between positive and general symptoms and cognitive performance. However, there was a significant association between scores on outcome measures on three out of the five cognitive tasks and negative symptom scores using PANSS, as follows: PRM (number correct) (Adj<italic>R</italic>2 = 0.15, <italic>F</italic>1,18 =4.91, <italic>p</italic>&lt;0.05), SRM (number correct) (Adj<italic>R</italic>2 = 0.13, <italic>F</italic>1,18 = 4.54, <italic>p</italic>&lt;0.05), IED (total errors) (Adj<italic>R</italic>2 = 0.35, <italic>F</italic>1,18 = 13.99, <italic>p</italic>&lt;0.001), SOC (mean number of moves) (Adj<italic>R</italic>2 =0.13, <italic>F</italic>1,18 = 4.60, <italic>p</italic>&lt;0.05), and CRT (total correct) (Adj<italic>R</italic>2 = 0.12, <italic>F</italic>1,18 =4.21, <italic>p</italic>&lt;0.05). There were no co-linear associations between any of the factors measured (<xref ref-type="table" rid="table4-0269881113477746">Table 4</xref>).</p>
<table-wrap id="table4-0269881113477746" position="float">
<label>Table 4.</label>
<caption>
<p>Regression analysis for negative symptoms scores and neuropsychological scores.</p>
</caption>
<graphic alternate-form-of="table4-0269881113477746" xlink:href="10.1177_0269881113477746-table4.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Cognitive measures</th>
<th align="left" colspan="4">PANSS negative score<hr/></th>
</tr>
<tr>
<th/>
<th align="left">Coef.</th>
<th align="left">Std. error</th>
<th align="left"><italic>t</italic></th>
<th align="left"><italic>p</italic> value</th>
</tr>
</thead>
<tbody>
<tr>
<td><bold>PRM</bold></td>
<td>−0.22</td>
<td>0.10</td>
<td>−2.22</td>
<td>&lt;0.05</td>
</tr>
<tr>
<td>Number correct</td>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td><bold>SRM</bold></td>
<td>−0.23</td>
<td>0.11</td>
<td>−2.13</td>
<td>&lt;0.05</td>
</tr>
<tr>
<td>Number correct</td>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td><bold>IED</bold></td>
<td>2.22</td>
<td>0.59</td>
<td>3.74</td>
<td>&lt;0.001</td>
</tr>
<tr>
<td>Total errors</td>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td><bold>SOC</bold></td>
<td>0.82</td>
<td>0.09</td>
<td>0.95</td>
<td>NS</td>
</tr>
<tr>
<td>Mean moves</td>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td><bold>CRT</bold></td>
<td>0.01</td>
<td>0.26</td>
<td>1.23</td>
<td>NS</td>
</tr>
<tr>
<td>Total correct</td>
<td/>
<td/>
<td/>
<td/>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn5-0269881113477746">
<p>Regression analysis: cognitive indices as dependent variables and negative symptoms as an independent variable.</p>
</fn>
<fn id="table-fn6-0269881113477746">
<p>Std error: standard error; Coef: individual regression coefficients; PRM: Pattern Recognition Memory; SRM: Spatial Recognition Memory; IED: Intra/Extra Dimensional Set Shift; SOC: Stockings of Cambridge; CRT: Choice Reaction Time.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
</sec>
<sec id="section23-0269881113477746" sec-type="discussion">
<title>Discussion</title>
<p>Our study replicates the findings of numerous studies that demonstrate the presence of cognitive deficits in patients with first episode psychosis on all domains tested including memory, executive function, planning and attention. We also found a significant association between negative symptoms and performance in certain cognitive domains including visual and spatial memory and executive function. However, we are the first to report a deficit in cognitive performance across a specific range of domains in South Asian first episode psychosis patients compared with a demographically and IQ matched South Asian control group. Our sample of first episode psychosis patients display a range of cognitive deficits which are similar to those seen in individuals with schizophrenia and also in other first episode psychosis studies (<xref ref-type="bibr" rid="bibr62-0269881113477746">Patel et al., 2006</xref>; <xref ref-type="bibr" rid="bibr63-0269881113477746">Rodriguez-Sanchez et al., 2007</xref>; <xref ref-type="bibr" rid="bibr68-0269881113477746">Townsend and Norman, 2004</xref>). In our study we also found evidence to support the hypothesis that negative symptom scores in patients are associated with cognitive deficits (<xref ref-type="bibr" rid="bibr5-0269881113477746">Ayres et al., 2007</xref>; <xref ref-type="bibr" rid="bibr30-0269881113477746">Grant and Beck, 2009</xref>), suggesting that impairments in cognition may be affected by symptom severity or that there may be a shared etiology for both domains of the illness.</p>
<p>The deficits in visual memory suggest that our patients have a reduced ability to discriminate between familiar and novel stimuli. These results add to the literature in that the same deficits are seen in a patient population who have not been studied before and are also in agreement with those found by <xref ref-type="bibr" rid="bibr47-0269881113477746">Levaux et al. (2007)</xref>, who showed that CANTAB has been used successfully to highlight the range of visuo-spatial cognitive deficits in schizophrenia, producing similar results to those obtained with some traditional neuropsychological tests.</p>
<p>Research investigating visual processing of non-facial information in schizophrenia has found that patients showed significantly reduced accuracy in visual detection of non-faces and that greater signal strength is required for visual and cognitive processing of non-facial information in patients (<xref ref-type="bibr" rid="bibr19-0269881113477746">Chen et al., 2009</xref>). The findings in the current study show that patients also have difficulty in visually processing abstract shapes and patterns and have a reduced ability to recall previously seen images which they may not be able to attach labels to, thus highlighting the need for greater signal strength for this process.</p>
<p>The deficits found in spatial memory in our study are in agreement with previous findings which have shown impairments on a visuo-spatial memory span task compared with other groups such as healthy controls and patients with other neurological disorders using subtests from the CANTAB (<xref ref-type="bibr" rid="bibr61-0269881113477746">Pantelis et al., 1997</xref>). Research has also shown how deficits in spatial memory exist in patients with schizophrenia compared with healthy controls and bipolar disorder patients and that poor visuo-spatial memory is a significant predictor of planning impairments, consistent with failures in goal selection, evaluation and/or execution (<xref ref-type="bibr" rid="bibr6-0269881113477746">Badcock et al., 2005</xref>). These deficits therefore have an adverse effect on the quality of life for the patients and can potentially affect their daily routines, for example, their ability to navigate and remember locations. Deficits in this domain are also related to deficits in working, short-term and long-term memory (<xref ref-type="bibr" rid="bibr3-0269881113477746">Ang and Lee, 2008</xref>; <xref ref-type="bibr" rid="bibr38-0269881113477746">Johnson and Adamo-Villani, 2010</xref>), which affects the ability to process and store important information.</p>
<p>Deficits seen in executive function in our patient group are typically observed in first episode and chronic schizophrenia patients. The results suggest that patients have difficulties with problem solving, multi-tasking, mental flexibility, monitoring of actions and initiation of actions. Previous research using the IED test from CANTAB has shown that there is a significant deficit in executive function in first episode and schizophrenia patients (<xref ref-type="bibr" rid="bibr13-0269881113477746">Braw et al., 2008</xref>; <xref ref-type="bibr" rid="bibr18-0269881113477746">Ceaser et al., 2008</xref>). These findings suggest that patients have difficulty in handling novel situations, decision making, troubleshooting and resisting temptation (<xref ref-type="bibr" rid="bibr58-0269881113477746">Norman and Shallice, 2000</xref>), which will all have a detrimental effect on functional outcome. The present research is the first to show that these deficits exist in South Asian patients through the use of CANTAB.</p>
<p>Previous research assessing planning ability in patients with schizophrenia and healthy controls found that the patient group performed worse than controls (<xref ref-type="bibr" rid="bibr70-0269881113477746">Tyson et al., 2004</xref>). Our results are in agreement with these findings, suggesting that patients have a reduced ability in forward planning when faced with problems of higher difficulty, for example, in the current study on the SOC test where the difficulty of the problem level was low, the patient group performed similarly to the control group. However, when the difficulty of the problems increased there was a rapid deterioration in the performance of the patient group only.</p>
<p>Deficits observed in the attention domain suggest that patients have problems in sustaining their attention over a period of time and also display slower reaction times compared with healthy controls. This lack of attention and slowness of reactions could potentially be caused by a number of different factors with medication side effects being one of the most poignant. Previous research has shown how attentional deficits are a core feature of cognitive symptoms in schizophrenia and are usually apparent before the onset of the illness (<xref ref-type="bibr" rid="bibr23-0269881113477746">Cornblatt and Keilp, 1994</xref>), again suggesting cognitive decline in the clinical high risk phase.</p>
<p>A possible limitation of the current study was relatively small numbers in both groups. However, we still found highly significant differences between the patient group and the control group in all of the cognitive domains assessed. We also found a relationship between negative symptom scores and performance in some of the neuropsychological tests with a large effect size in a relatively small sample. Another potential strength of the study was that we excluded any patients with co-morbid substance misuse therefore eliminating the effects of excess drugs or alcohol use on cognitive performance. In future investigations we will attempt to increase the sample size and have a more balanced male to female ratio. Similar to most other research in this area there appears to be a lack of females participating in the research. Although it has been well documented that the incidence rate of psychosis is higher in males than females (<xref ref-type="bibr" rid="bibr51-0269881113477746">McGrath et al., 2004</xref>) females are still disproportionately underrepresented in non-epidemiological schizophrenia research. One suggestion as to why this is the case is that women with schizophrenia may be less likely to enter the treatment settings where most clinical research is conducted (<xref ref-type="bibr" rid="bibr49-0269881113477746">Longenecker et al., 2010</xref>). Our study was conducted in South Asians patients; whether there are additional social pressures that make it more difficult for women in this ethnic group to access services or research studies than for men is unclear. In addition, it may be that women display different symptomatology from men and that these differences are not always apparent at onset, but rather develop as the illness progresses (<xref ref-type="bibr" rid="bibr31-0269881113477746">Grossman et al., 2006</xref>; <xref ref-type="bibr" rid="bibr74-0269881113477746">Willhite et al., 2008</xref>).</p>
<p>The results from the present study and similar studies are vital to improve our understanding of the nature of cognitive deficits in South Asian patients and other ethnic groups. Similar to the research by <xref ref-type="bibr" rid="bibr45-0269881113477746">Krishnadas et al. (2007)</xref>, we found that cognitive deficits in this patient group are comparable to those found in other ethnic groups. However, unlike their findings, we reported a predictive relationship between some neuropsychological scores and negative symptom scores. Research by <xref ref-type="bibr" rid="bibr50-0269881113477746">McCreadie et al. (1997)</xref> in patients living in South East India also found a relationship between negative symptoms and memory but only in never-treated patients. Our study extends this finding by replicating it in medicated first episode South Asian patients in the UK. The results from these findings will, hopefully, contribute to the literature which suggests that improvements need to be made in addressing the issue of cognitive deficits. These improvements not only include appropriately administered pharmacotherapy, but must also include targeted cognitive remediation for sustained improvements (<xref ref-type="bibr" rid="bibr75-0269881113477746">Wykes et al., 2011</xref>).</p>
<p>In conclusion, first episode South Asian patients display significant cognitive deficits across a number of domains when tested using CANTAB. To our knowledge this is the first study to examine cognitive deficits in a South Asian population in the UK compared with a demographically and IQ matched control group. It is also the first study to use this particular bespoke CANTAB battery in a population of first episode psychosis patients. Our findings add to the literature that cognitive deficits are homogenous in nature regardless of the ethnic background of the patients. The results suggest that population based neuropsychological studies of first episode psychosis in minority populations are important and allow for further investigations to examine whether the course of their deficits changes in the same way as in other patient groups. Finally our work demonstrates that more needs to be done with respect to helping patients improve their cognition through the combined use of pharmacological therapies and cognitive remediation therapy. For future investigations the inclusion of a group of long term schizophrenia patients from the same ethnic population would allow for further comparisons to be made with respect to severity of cognitive decline and its association with longitudinal outcomes. In addition, studies of cognitive remediation and pharmacotherapy targeted to cognitive deficits in this and other patient populations will be essential to enhance our understanding of how best to improve outcome for these patients.</p>
</sec>
</body>
<back>
<ack><p>The authors would like to thank Dr Peter Haddad for his most helpful and insightful comments.</p></ack>
<fn-group>
<fn fn-type="conflict">
<label>Conflict of interest</label>
<p>The authors declare that there is no conflict of interest.</p>
</fn>
<fn fn-type="financial-disclosure">
<label>Funding</label>
<p>This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Addington</surname><given-names>J</given-names></name>
<name><surname>Addington</surname><given-names>D</given-names></name>
</person-group> (<year>1999</year>) <article-title>Neurocognitive and social functioning in schizophrenia</article-title>. <source>Schizophr Bull</source> <volume>25</volume>: <fpage>173</fpage>–<lpage>182</lpage>.</citation>
</ref>
<ref id="bibr2-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Allott</surname><given-names>K</given-names></name>
<name><surname>Liu</surname><given-names>P</given-names></name>
<name><surname>Proffitt</surname><given-names>TM</given-names></name><etal/>
</person-group> (<year>2011</year>) <article-title>Cognition at illness onset as a predictor of later functional outcome in early psychosis: Systematic review and methodological critique</article-title>. <source>Schizophr Res</source> <volume>125</volume>: <fpage>221</fpage>–<lpage>235</lpage>.</citation>
</ref>
<ref id="bibr3-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ang</surname><given-names>SY</given-names></name>
<name><surname>Lee</surname><given-names>K</given-names></name>
</person-group> (<year>2008</year>) <article-title>Central executive involvement in children’s spatial memory</article-title>. <source>Memory</source> <volume>16</volume>: <fpage>918</fpage>–<lpage>933</lpage>.</citation>
</ref>
<ref id="bibr4-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Altshuler</surname><given-names>LL</given-names></name>
<name><surname>Ventura</surname><given-names>J</given-names></name>
<name><surname>van Gorp</surname><given-names>W</given-names></name><etal/>
</person-group> (<year>2004</year>) <article-title>Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects</article-title>. <source>Biol Psychiatry</source> <volume>56</volume>: <fpage>560</fpage>–<lpage>569</lpage>.</citation>
</ref>
<ref id="bibr5-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ayres</surname><given-names>AM</given-names></name>
<name><surname>Busatto</surname><given-names>GF</given-names></name>
<name><surname>Menezes</surname><given-names>P</given-names></name><etal/>
</person-group> (<year>2007</year>) <article-title>Cognitive deficits in first-episode psychosis: A population based study in Sao Paulo, Brazil</article-title>. <source>Schizophr Res</source> <volume>90</volume>: <fpage>338</fpage>–<lpage>343</lpage>.</citation>
</ref>
<ref id="bibr6-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Badcock</surname><given-names>JC</given-names></name>
<name><surname>Michiel</surname><given-names>PT</given-names></name>
<name><surname>Rock</surname><given-names>D</given-names></name>
</person-group> (<year>2005</year>) <article-title>Spatial working memory and planning ability: Contrasts between schizophrenia and bipolar I disorder</article-title>. <source>Cortex</source> <volume>41</volume>: <fpage>753</fpage>–<lpage>763</lpage>.</citation>
</ref>
<ref id="bibr7-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Barbato</surname><given-names>M</given-names></name>
<name><surname>Colijn</surname><given-names>M</given-names></name>
<name><surname>Keefe</surname><given-names>R</given-names></name><etal/>
</person-group> (<year>2012</year>) <article-title>The course of cognitive functioning over six months in individuals at clinical high risk for psychosis</article-title>. <source>Psychiatry Res</source>; DOI:<pub-id pub-id-type="doi">10.1016/j.psychres.2012.10.013</pub-id> [Epub ahead of print].</citation>
</ref>
<ref id="bibr8-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Barnett</surname><given-names>JH</given-names></name>
<name><surname>Sahakian</surname><given-names>BJ</given-names></name>
<name><surname>Werners</surname><given-names>U</given-names></name><etal/>
</person-group> (<year>2005</year>) <article-title>Visuospatial learning and executive function are independently impaired in first episode psychosis</article-title>. <source>Psychol Med</source> <volume>35</volume>: <fpage>1031</fpage>–<lpage>1041</lpage>.</citation>
</ref>
<ref id="bibr9-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bhugra</surname><given-names>D</given-names></name>
<name><surname>Leff</surname><given-names>J</given-names></name>
<name><surname>Mallett</surname><given-names>R</given-names></name><etal/>
</person-group> (<year>1997</year>) <article-title>Incidence and outcome of schizophrenia in Whites, African-Caribbeans and Asians in London</article-title>. <source>Psychol Med</source> <volume>27</volume>: <fpage>791</fpage>–<lpage>798</lpage>.</citation>
</ref>
<ref id="bibr10-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bilder</surname><given-names>RM</given-names></name>
<name><surname>Goldman</surname><given-names>RS</given-names></name>
<name><surname>Robinson</surname></name><etal/>
</person-group> (<year>2000</year>) <article-title>Neuropsychology of first episode schizophrenia: initial characterization and clinical correlates</article-title>. <source>Am J Psychiatry</source> <volume>157</volume>: <fpage>549</fpage>–<lpage>559</lpage>.</citation>
</ref>
<ref id="bibr11-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bozikas</surname><given-names>VP</given-names></name>
<name><surname>Andreou</surname><given-names>C</given-names></name>
</person-group> (<year>2011</year>) <article-title>Longitudinal studies of cognition in first episode psychosis: A systematic review of the literature</article-title>. <source>Aust N Z J Psychiatry</source> <volume>45</volume>: <fpage>93</fpage>–<lpage>108</lpage>.</citation>
</ref>
<ref id="bibr12-0269881113477746">
<citation citation-type="book"><collab>Bradford City Strategy</collab> (<year>2008</year>) <source>Adult mental health commissioning strategy and plan 2008–2011. Health needs analysis</source>. <publisher-loc>Bradford, UK</publisher-loc>: <publisher-name>City of Bradford Metropolitan District Council</publisher-name>.</citation>
</ref>
<ref id="bibr13-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Braw</surname><given-names>Y</given-names></name>
<name><surname>Bloch</surname><given-names>Y</given-names></name>
<name><surname>Mendelovich</surname><given-names>S</given-names></name><etal/>
</person-group> (<year>2008</year>) <article-title>Cognition in young schizophrenia outpatients: Comparison of first-episode with multi episode patients</article-title>. <source>Schizophr Bull</source> <volume>34</volume>: <fpage>544</fpage>–<lpage>554</lpage>.</citation>
</ref>
<ref id="bibr14-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Buchanan</surname><given-names>RW</given-names></name>
<name><surname>Freedman</surname><given-names>R</given-names></name>
<name><surname>Javitt</surname><given-names>DC</given-names></name><etal/>
</person-group> (<year>2007</year>) <article-title>Recent advances in the development of novel pharmacological agents for the treatment of cognitive impairments in schizophrenia</article-title>. <source>Schizophr Bull</source> <volume>33</volume>: <fpage>1120</fpage>–<lpage>1130</lpage>.</citation>
</ref>
<ref id="bibr15-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cannon</surname><given-names>TD</given-names></name>
<name><surname>Huttunen</surname><given-names>MO</given-names></name>
<name><surname>Lonnqvist</surname><given-names>J</given-names></name><etal/>
</person-group> (<year>2000</year>) <article-title>The inheritance of neuropsychological dysfunction in twins discordant for schizophrenia</article-title>. <source>Am J Hum Genet</source> <volume>67</volume>: <fpage>369</fpage>–<lpage>382</lpage>.</citation>
</ref>
<ref id="bibr16-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cantor-Graae</surname><given-names>E</given-names></name>
<name><surname>Selten</surname><given-names>JP</given-names></name>
</person-group> (<year>2005</year>) <article-title>Schizophrenia and migration: A meta-analysis and review</article-title>. <source>Am J Psychiatry</source> <volume>162</volume>: <fpage>12</fpage>–<lpage>24</lpage>.</citation>
</ref>
<ref id="bibr17-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Carter</surname><given-names>CS</given-names></name>
<name><surname>Barch</surname><given-names>DM</given-names></name>
</person-group> (<year>2007</year>) <article-title>Cognitive neuroscience-based approaches to measuring and improving treatment effects on cognition in schizophrenia: The CNTRICS initiative</article-title>. <source>Schizophr Bull</source> <volume>33</volume>: <fpage>1131</fpage>–<lpage>1137</lpage>.</citation>
</ref>
<ref id="bibr18-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ceaser</surname><given-names>AE</given-names></name>
<name><surname>Goldberg</surname><given-names>TE</given-names></name>
<name><surname>Egan</surname><given-names>MF</given-names></name><etal/>
</person-group> (<year>2008</year>) <article-title>Set shifting ability and schizophrenia: A marker of clinical illness or an intermediate phenotype?</article-title> <source>Biol Psychiatry</source> <volume>64</volume>: <fpage>782</fpage>–<lpage>788</lpage>.</citation>
</ref>
<ref id="bibr19-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chen</surname><given-names>Y</given-names></name>
<name><surname>Norton</surname><given-names>D</given-names></name>
<name><surname>McBain</surname><given-names>R</given-names></name><etal/>
</person-group> (<year>2009</year>) <article-title>Visual and cognitive processing of face information in schizophrenia: Detection, discrimination and working memory</article-title>. <source>Schizophr Res</source> <volume>1</volume>: <fpage>92</fpage>-<lpage>98</lpage>.</citation>
</ref>
<ref id="bibr20-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cockrell</surname><given-names>JR</given-names></name>
<name><surname>Folstein</surname><given-names>MF</given-names></name>
</person-group> (<year>1998</year>) <article-title>Mini-Mental State Examination (MMSE)</article-title>. <source>Psychopharmacol Bull</source> <volume>24</volume>: <fpage>689</fpage>–<lpage>692</lpage>.</citation>
</ref>
<ref id="bibr21-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Coid</surname><given-names>JW</given-names></name>
<name><surname>Kirkbride</surname><given-names>JB</given-names></name>
<name><surname>Barker</surname><given-names>D</given-names></name><etal/>
</person-group> (<year>2008</year>) <article-title>Raised incidence rates of all psychoses among migrant groups: Findings from the East London first episode psychosis study</article-title>. <source>Arch Gen Psychiatry</source> <volume>65</volume>: <fpage>1250</fpage>–<lpage>1258</lpage>.</citation>
</ref>
<ref id="bibr22-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cornblatt</surname><given-names>BA</given-names></name>
</person-group> (<year>2002</year>) <article-title>New York high risk project to the Hillside recognition and prevention (RAP) program</article-title>. <source>Am J Med Genet</source> <volume>114</volume>: <fpage>956</fpage>–<lpage>966</lpage>.</citation>
</ref>
<ref id="bibr23-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cornblatt</surname><given-names>BA</given-names></name>
<name><surname>Keilp</surname><given-names>JG</given-names></name>
</person-group> (<year>1994</year>) <article-title>Impaired attention, genetics, and the pathophysiology of schizophrenia</article-title>. <source>Schizophr Bull</source> <volume>20</volume>: <fpage>31</fpage>–<lpage>46</lpage>.</citation>
</ref>
<ref id="bibr24-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Faber</surname><given-names>G</given-names></name>
<name><surname>van Gool</surname><given-names>AR</given-names></name>
<name><surname>Smid</surname><given-names>HG</given-names></name><etal/>
</person-group> (<year>2011</year>) <article-title>Typical and atypical antipsychotics: Is there a difference in their influence on neurocognition?</article-title> <source>Tijdschr Psychiatr</source> <volume>2</volume>: <fpage>107</fpage>–<lpage>117</lpage>.</citation>
</ref>
<ref id="bibr25-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fagerlund</surname><given-names>B</given-names></name>
<name><surname>Pagsberg</surname><given-names>AK</given-names></name>
<name><surname>Hemmingsen</surname><given-names>R</given-names></name>
</person-group> (<year>2006</year>) <article-title>Cognitive deficits and levels of IQ in adolescent onset schizophrenia and other psychotic disorders</article-title>. <source>Schizophr Res</source> <volume>85</volume>: <fpage>30</fpage>-<lpage>39</lpage>.</citation>
</ref>
<ref id="bibr26-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fearon</surname><given-names>P</given-names></name>
<name><surname>Kirkbride</surname><given-names>JB</given-names></name>
<name><surname>Morgan</surname><given-names>C</given-names></name><etal/>
</person-group> (<year>2006</year>) <article-title>Incidence of schizophrenia and other psychoses in ethnic minority groups: Results from the MRC AESOP Study</article-title>. <source>Psychol Med</source> <volume>36</volume>: <fpage>1541</fpage>–<lpage>1550</lpage>.</citation>
</ref>
<ref id="bibr27-0269881113477746">
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>First</surname><given-names>MB</given-names></name>
<name><surname>Spitzer</surname><given-names>RL</given-names></name>
<name><surname>Gibbon</surname><given-names>M</given-names></name><etal/>
</person-group> (<year>1998</year>) <source>Structured Clinical Interview for DSM-IV Axis I Disorders</source>. <publisher-loc>New York</publisher-loc>: <publisher-name>Biometrics Research Department, New York State Psychiatric Institute</publisher-name>.</citation>
</ref>
<ref id="bibr28-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Frommann</surname><given-names>I</given-names></name>
<name><surname>Pukrop</surname><given-names>R</given-names></name>
<name><surname>Brinkmeyer</surname><given-names>J</given-names></name><etal/>
</person-group> (<year>2011</year>) <article-title>Neuropsychological profiles in different at-risk states of psychosis: Executive control impairment in the early – and additional memory dysfunction in the late – prodromal state</article-title>. <source>Schizophr Bull</source> <volume>37</volume>: <fpage>861</fpage>–<lpage>873</lpage>.</citation>
</ref>
<ref id="bibr29-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gopin</surname><given-names>CB</given-names></name>
<name><surname>Burdick</surname><given-names>KE</given-names></name>
<name><surname>Derosse</surname><given-names>P</given-names></name><etal/>
</person-group> (<year>2011</year>) <article-title>Emotional modulation of response inhibition in stable patients with bipolar I disorder: A comparison with healthy and schizophrenia subjects</article-title>. <source>Bipolar Disord</source> <volume>13</volume>: <fpage>164</fpage>–<lpage>172</lpage>.</citation>
</ref>
<ref id="bibr30-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Grant</surname><given-names>PM</given-names></name>
<name><surname>Beck</surname><given-names>AT</given-names></name>
</person-group> (<year>2009</year>) <article-title>Defeatist beliefs as a mediator of cognitive impairment, negative symptoms, and functioning in schizophrenia</article-title>. <source>Schizophr Bull</source> <volume>35</volume>: <fpage>798</fpage>–<lpage>806</lpage>.</citation>
</ref>
<ref id="bibr31-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Grossman</surname><given-names>L</given-names></name>
<name><surname>Harrow</surname><given-names>M</given-names></name>
<name><surname>Rosen</surname><given-names>C</given-names></name><etal/>
</person-group> (<year>2006</year>). <article-title>Sex differences in outcome and recovery for schizophrenia and other psychotic and nonpsychotic disorders</article-title>. <source>Psychiatr Serv</source> <volume>57</volume>: <fpage>844</fpage>–<lpage>850</lpage>.</citation>
</ref>
<ref id="bibr32-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Habets</surname><given-names>P</given-names></name>
<name><surname>Krabbendam</surname><given-names>L</given-names></name>
<name><surname>Hofman</surname><given-names>P</given-names></name><etal/>
</person-group> (<year>2008</year>) <article-title>Cognitive performance and grey matter density in psychosis: Functional relevance of a structural endophenotype</article-title>. <source>Neuropsychobiology</source> <volume>58</volume>: <fpage>128</fpage>–<lpage>137</lpage>.</citation>
</ref>
<ref id="bibr33-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Harrison</surname><given-names>G.</given-names></name>
<name><surname>Owens</surname><given-names>D.</given-names></name>
<name><surname>Holton</surname><given-names>A.</given-names></name><etal/>
</person-group> (<year>1988</year>) <article-title>A prospective study of severe mental disorder in Afro-Caribbean patients</article-title>. <source>Psychological Medicine</source>, <volume>18</volume>, <fpage>643</fpage>–<lpage>657</lpage>.</citation>
</ref>
<ref id="bibr34-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Harvey</surname><given-names>PD</given-names></name>
<name><surname>Keefe</surname><given-names>RS</given-names></name>
</person-group> (<year>2001</year>) <article-title>Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment</article-title>. <source>Am J Psychiatry</source> <volume>158</volume>: <fpage>176</fpage>–<lpage>184</lpage>.</citation>
</ref>
<ref id="bibr35-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Harvey</surname><given-names>PD</given-names></name>
<name><surname>Koren</surname><given-names>D</given-names></name>
<name><surname>Reichenberg</surname><given-names>A</given-names></name><etal/>
</person-group> (<year>2006</year>) <article-title>Negative symptoms and cognitive deficits: What is the nature of their relationship?</article-title> <source>Schizophr Bull</source> <volume>32</volume>: <fpage>250</fpage>–<lpage>258</lpage>.</citation>
</ref>
<ref id="bibr36-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Heinrichs</surname><given-names>RW</given-names></name>
<name><surname>Zakzanis</surname><given-names>KK</given-names></name>
</person-group> (<year>1998</year>) <article-title>Neurocognitive deficit in schizophrenia: A quantitative review of the evidence</article-title>. <source>Neuropsychology</source> <volume>12</volume>: <fpage>426</fpage>–<lpage>445</lpage>.</citation>
</ref>
<ref id="bibr37-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Huddy</surname><given-names>VC</given-names></name>
<name><surname>Hodgson</surname><given-names>TL</given-names></name>
<name><surname>Kapasi</surname><given-names>M</given-names></name><etal/>
</person-group> (<year>2007</year>) <article-title>Gaze strategies during planning in first-episode psychosis</article-title>. <source>J Abnorm Psychol</source> <volume>116</volume>: <fpage>589</fpage>–<lpage>598</lpage>.</citation>
</ref>
<ref id="bibr38-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Johnson</surname><given-names>E</given-names></name>
<name><surname>Adamo-Villani</surname><given-names>N</given-names></name>
</person-group> (<year>2010</year>) <article-title>A study of the effects of immersion on short-term spatial memory</article-title>. <source>Eng Technol</source> <volume>71</volume>: <fpage>582</fpage>–<lpage>587</lpage>.</citation>
</ref>
<ref id="bibr39-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kay</surname><given-names>SR</given-names></name>
<name><surname>Opler</surname><given-names>LA</given-names></name>
</person-group> (<year>1987</year>) <article-title>The positive-negative dimension in schizophrenia: Its validity and significance</article-title>. <source>Psychiatr Dev</source> <volume>5</volume>: <fpage>79</fpage>–<lpage>103</lpage>.</citation>
</ref>
<ref id="bibr40-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kay</surname><given-names>SR</given-names></name>
<name><surname>Singh</surname><given-names>MM</given-names></name>
</person-group> (<year>1989</year>) <article-title>The positive-negative distinction in drug-free schizophrenic patients. Stability, response to neuroleptics, and prognostic significance</article-title>. <source>Arch Gen Psychiatry</source> <volume>46</volume>: <fpage>711</fpage>–<lpage>718</lpage>.</citation>
</ref>
<ref id="bibr41-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kay</surname><given-names>SR</given-names></name>
<name><surname>Fiszbein</surname><given-names>A</given-names></name>
<name><surname>Opler</surname><given-names>LA</given-names></name>
</person-group> (<year>1987</year>) <article-title>The positive and negative syndrome scale (PANSS) for schizophrenia</article-title>. <source>Schizophr Bull</source> <volume>13</volume>: <fpage>261</fpage>–<lpage>276</lpage>.</citation>
</ref>
<ref id="bibr42-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kay</surname><given-names>SR</given-names></name>
<name><surname>Opler</surname><given-names>LA</given-names></name>
<name><surname>Fiszbein</surname><given-names>A</given-names></name>
</person-group> (<year>1986</year>) <article-title>Significance of positive and negative syndromes in chronic schizophrenia</article-title>. <source>Br J Psychiatry</source> <volume>149</volume>: <fpage>439</fpage>–<lpage>448</lpage>.</citation>
</ref>
<ref id="bibr43-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kay</surname><given-names>SR</given-names></name>
<name><surname>Opler</surname><given-names>LA</given-names></name>
<name><surname>Lindenmayer</surname><given-names>JP</given-names></name>
</person-group> (<year>1989</year>) <article-title>The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation</article-title>. <source>Br J Psychiatry</source> <volume>155</volume> (<supplement>suppl. 7</supplement>): <fpage>59</fpage>–<lpage>65</lpage>.</citation>
</ref>
<ref id="bibr44-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kirkbride</surname><given-names>JB</given-names></name>
<name><surname>Barker</surname><given-names>D</given-names></name>
<name><surname>Cowden</surname><given-names>F</given-names></name><etal/>
</person-group> (<year>2008</year>) <article-title>Psychoses, ethnicity and socio-economic status</article-title>. <source>Br J Psychiatry</source> <volume>193</volume>: <fpage>18</fpage>–<lpage>24</lpage>.</citation>
</ref>
<ref id="bibr45-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Krishnadas</surname><given-names>R</given-names></name>
<name><surname>Moore</surname><given-names>BP</given-names></name>
<name><surname>Nayak</surname><given-names>A</given-names></name><etal/>
</person-group> (<year>2007</year>) <article-title>Relationship of cognitive function in patients with schizophrenia in remission to disability: A cross-sectional study in an Indian sample</article-title>. <source>Ann Gen Psychiatry</source> <volume>6</volume>: <fpage>19</fpage>.</citation>
</ref>
<ref id="bibr46-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kuha</surname><given-names>A</given-names></name>
<name><surname>Tuulio-Henriksson</surname><given-names>A</given-names></name>
<name><surname>Eerola</surname><given-names>M</given-names></name><etal/>
</person-group> (<year>2007</year>) <article-title>Impaired executive performance in healthy siblings of schizophrenia patients in a population-based study</article-title>. <source>Schizophr Res</source> <volume>92</volume>: <fpage>142</fpage>–<lpage>150</lpage>.</citation>
</ref>
<ref id="bibr47-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Levaux</surname><given-names>MN</given-names></name>
<name><surname>Potvin</surname><given-names>S</given-names></name>
<name><surname>Sepehry</surname><given-names>AA</given-names></name><etal/>
</person-group> (<year>2007</year>) <article-title>Computerized assessment of cognition in schizophrenia: Promises and pitfalls of CANTAB</article-title>. <source>Eur Psychiatry</source> <volume>22</volume>: <fpage>104</fpage>–<lpage>115</lpage>.</citation>
</ref>
<ref id="bibr48-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lindenmayer</surname><given-names>JP</given-names></name>
<name><surname>Kay</surname><given-names>SR</given-names></name>
<name><surname>Opler</surname><given-names>L</given-names></name>
</person-group> (<year>1984</year>) <article-title>Positive and negative subtypes in acute schizophrenia</article-title>. <source>Compr Psychiatry</source> <volume>25</volume>: <fpage>455</fpage>–<lpage>464</lpage>.</citation>
</ref>
<ref id="bibr49-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Longenecker</surname><given-names>J</given-names></name>
<name><surname>Genderson</surname><given-names>J</given-names></name>
<name><surname>Dickinson</surname><given-names>D</given-names></name><etal/>
</person-group> (<year>2010</year>) <article-title>Where have all the women gone? Participant gender in epidemiological and non-epidemiological research of schizophrenia</article-title>. <source>Schizophr Res</source> <volume>119</volume>: <fpage>240</fpage>–<lpage>245</lpage>.</citation>
</ref>
<ref id="bibr50-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>McCreadie</surname><given-names>RG</given-names></name>
<name><surname>Latha</surname><given-names>S</given-names></name>
<name><surname>Thara</surname><given-names>R</given-names></name><etal/>
</person-group> (<year>1997</year>) <article-title>Poor memory, negative symptoms and abnormal movements in never-treated Indian patients with schizophrenia</article-title>. <source>Br J Psychiatry</source> <volume>171</volume>: <fpage>360</fpage>–<lpage>373</lpage>.</citation>
</ref>
<ref id="bibr51-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>McGrath</surname><given-names>J</given-names></name>
<name><surname>Saha</surname><given-names>S</given-names></name>
<name><surname>Welham</surname><given-names>J</given-names></name><etal/>
</person-group> (<year>2004</year>) <article-title>A systematic review of the incidence of schizophrenia: The distribution of rates and the influence of sex, urbanicity, migrant status and methodology</article-title>. <source>BMC Med</source> <volume>2</volume>: <fpage>13</fpage>.</citation>
</ref>
<ref id="bibr52-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>McGurk</surname><given-names>SR</given-names></name>
<name><surname>Meltzer</surname><given-names>HY</given-names></name>
</person-group> (<year>2000</year>) <article-title>The role of cognition in vocational functioning in schizophrenia</article-title>. <source>Schizophr Res</source> <volume>45</volume>: <fpage>175</fpage>–<lpage>184</lpage>.</citation>
</ref>
<ref id="bibr53-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Marder</surname><given-names>SR</given-names></name>
</person-group> (<year>2006</year>) <article-title>The NIMH-MATRICS project for developing cognition-enhancing agents for schizophrenia</article-title>. <source>Dialogues Clin Neurosci</source> <volume>8</volume>: <fpage>109</fpage>–<lpage>113</lpage>.</citation>
</ref>
<ref id="bibr54-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Marder</surname><given-names>SR</given-names></name>
<name><surname>Fenton</surname><given-names>W</given-names></name>
</person-group> (<year>2004</year>) <article-title>Measurement and Treatment Research to Improve Cognition in Schizophrenia: NIMH MATRICS initiative to support the development of agents for improving cognition in schizophrenia</article-title>. <source>Schizophr Res</source> <volume>72</volume>: <fpage>5</fpage>–<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr55-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mesholam-Gately</surname><given-names>RI</given-names></name>
<name><surname>Giuliano</surname><given-names>AJ</given-names></name>
<name><surname>Goff</surname><given-names>KP</given-names></name><etal/>
</person-group> (<year>2009</year>) <article-title>Neurocognition in first-episode schizophrenia: A meta-analytic review</article-title>. <source>Neuropsychology</source> <volume>23</volume>: <fpage>315</fpage>–<lpage>336</lpage>.</citation>
</ref>
<ref id="bibr56-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mohamed</surname><given-names>S</given-names></name>
<name><surname>Paulsen</surname><given-names>JS</given-names></name>
<name><surname>O’Leary</surname><given-names>D</given-names></name><etal/>
</person-group> (<year>1999</year>) <article-title>Generalized cognitive deficits in schizophrenia: A study of first-episode patients</article-title>. <source>Arch Gen Psychiatry</source> <volume>56</volume>: <fpage>749</fpage>–<lpage>754</lpage>.</citation>
</ref>
<ref id="bibr57-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mulet</surname><given-names>B</given-names></name>
<name><surname>Valero</surname><given-names>J</given-names></name>
<name><surname>Gutierrez-Zotes</surname><given-names>A</given-names></name><etal/>
</person-group> (<year>2007</year>) <article-title>Sustained and selective attention deficits as vulnerability markers to psychosis</article-title>. <source>Eur Psychiatry</source> <volume>22</volume>: <fpage>171</fpage>–<lpage>176</lpage>.</citation>
</ref>
<ref id="bibr58-0269881113477746">
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Norman</surname><given-names>DA</given-names></name>
<name><surname>Shallice</surname><given-names>T</given-names></name>
</person-group> (<year>2000</year>) <article-title>Attention to action: Willed and automatic control of behavior</article-title>. In: <person-group person-group-type="editor">
<name><surname>Gazzaniga</surname><given-names>MS</given-names></name>
</person-group> (ed.) <source>Cognitive Neuroscience: A Reader</source>. <publisher-loc>New York</publisher-loc>: <publisher-name>Wiley Blackwell</publisher-name>.</citation>
</ref>
<ref id="bibr59-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nuechterlein</surname><given-names>KH</given-names></name>
<name><surname>Subotnik</surname><given-names>KL</given-names></name>
<name><surname>Green</surname><given-names>MF</given-names></name><etal/>
</person-group> (<year>2011</year>) <article-title>Neurocognitive predictors of work outcome in recent onset schizophrenia</article-title>. <source>Schizophr Bull</source> <volume>37</volume>(<supplement>Suppl. 2</supplement>): <fpage>S33</fpage>–<lpage>S40</lpage>.</citation>
</ref>
<ref id="bibr60-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Owen</surname><given-names>AM</given-names></name>
<name><surname>Downes</surname><given-names>JJ</given-names></name>
<name><surname>Sahakian</surname><given-names>BJ</given-names></name><etal/>
</person-group> (<year>1990</year>) <article-title>Planning and spatial working memory following frontal lobe lesions in man</article-title>. <source>Neuropsychologia</source> <volume>28</volume>: <fpage>1021</fpage>–<lpage>1034</lpage>.</citation>
</ref>
<ref id="bibr61-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pantelis</surname><given-names>C</given-names></name>
<name><surname>Barnes</surname><given-names>TR</given-names></name>
<name><surname>Nelson</surname><given-names>HE</given-names></name><etal/>
</person-group> (<year>1997</year>) <article-title>Frontal-striatal cognitive deficits in patients with chronic schizophrenia</article-title>. <source>Brain</source> <volume>120</volume>: <fpage>1823</fpage>–<lpage>1843</lpage>.</citation>
</ref>
<ref id="bibr62-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Patel</surname><given-names>A</given-names></name>
<name><surname>Everitt</surname><given-names>B</given-names></name>
<name><surname>Knapp</surname><given-names>M</given-names></name><etal/>
</person-group> (<year>2006</year>) <article-title>Schizophrenia patients with cognitive deficits: Factors associated with costs</article-title>. <source>Schizophr Bull</source> <volume>32</volume>: <fpage>776</fpage>–<lpage>785</lpage>.</citation>
</ref>
<ref id="bibr63-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rodriguez-Sanchez</surname><given-names>JM</given-names></name>
<name><surname>Crespo-Facorro</surname><given-names>B</given-names></name>
<name><surname>Gonzalez-Blanch</surname><given-names>C</given-names></name><etal/>
</person-group> (<year>2007</year>) <article-title>Cognitive dysfunction in first-episode psychosis: The processing speed hypothesis</article-title>. <source>Br J Psychiatry Suppl</source> <volume>51</volume>: <fpage>s107</fpage>–<lpage>s110</lpage>.</citation>
</ref>
<ref id="bibr64-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sahakian</surname><given-names>BJ</given-names></name>
<name><surname>Owen</surname><given-names>AM</given-names></name>
</person-group> (<year>1992</year>) <article-title>Computerized assessment in neuropsychiatry using CANTAB: Discussion paper</article-title>. <source>J R Soc Med</source> <volume>85</volume>: <fpage>399</fpage>–<lpage>402</lpage>.</citation>
</ref>
<ref id="bibr65-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sahakian</surname><given-names>BJ</given-names></name>
<name><surname>Morris</surname><given-names>RG</given-names></name>
<name><surname>Evenden</surname><given-names>JL</given-names></name><etal/>
</person-group> (<year>1988</year>) <article-title>A comparative study of visuospatial memory and learning in Alzheimer-type dementia and Parkinsons disease</article-title>. <source>Brain</source> <volume>111</volume>: <fpage>695</fpage>–<lpage>718</lpage>.</citation>
</ref>
<ref id="bibr66-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Shallice</surname><given-names>T</given-names></name>
</person-group> (<year>1982</year>) <article-title>Specific impairments of planning</article-title>. <source>Phil Trans R Soc Lond B</source> <volume>298</volume>: <fpage>199</fpage>–<lpage>209</lpage>.</citation>
</ref>
<ref id="bibr67-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Singh</surname><given-names>SP</given-names></name>
<name><surname>Burns</surname><given-names>T</given-names></name>
</person-group> (<year>2006</year>) <article-title>Race and mental health: There is more to race than racism</article-title>. <source>BMJ</source> <volume>333</volume>: <fpage>648</fpage>–<lpage>651</lpage>.</citation>
</ref>
<ref id="bibr68-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Townsend</surname><given-names>LA</given-names></name>
<name><surname>Norman</surname><given-names>RM</given-names></name>
</person-group> (<year>2004</year>) <article-title>Course of cognitive functioning in first episode schizophrenia spectrum disorders</article-title>. <source>Expert Rev Neurother</source> <volume>4</volume>: <fpage>61</fpage>–<lpage>68</lpage>.</citation>
</ref>
<ref id="bibr69-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Townsend</surname><given-names>LA</given-names></name>
<name><surname>Malla</surname><given-names>AK</given-names></name>
<name><surname>Norman</surname><given-names>RM</given-names></name>
</person-group> (<year>2001</year>) <article-title>Cognitive functioning in stabilized first-episode psychosis patients</article-title>. <source>Psychiatry Res</source> <volume>104</volume>:<fpage>119</fpage>–<lpage>131</lpage>.</citation>
</ref>
<ref id="bibr70-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tyson</surname><given-names>PJ</given-names></name>
<name><surname>Laws</surname><given-names>KR</given-names></name>
<name><surname>Roberts</surname><given-names>KH</given-names></name><etal/>
</person-group> (<year>2004</year>) <article-title>Stability of set-shifting and planning abilities in patients with schizophrenia</article-title>. <source>Psychiatry Res</source> <volume>129</volume>: <fpage>229</fpage>–<lpage>239</lpage>.</citation>
</ref>
<ref id="bibr71-0269881113477746">
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Wechsler</surname><given-names>D</given-names></name>
</person-group> (<year>1997</year>) <source>Wechsler Adult Intelligence Scale–3rd Edition (WAIS-3)</source>. <publisher-loc>San Antonio, TX</publisher-loc>: <publisher-name>Harcourt Assessment</publisher-name>.</citation>
</ref>
<ref id="bibr72-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Weickert</surname><given-names>TW</given-names></name>
<name><surname>Goldberg</surname><given-names>TE</given-names></name>
<name><surname>Egan</surname><given-names>MF</given-names></name><etal/>
</person-group> (<year>2010</year>) <article-title>Relative risk of probabilistic category learning deficits in patients with schizophrenia and their siblings</article-title>. <source>Biol Psychiatry</source> <volume>67</volume>: <fpage>948</fpage>-<lpage>955</lpage>.</citation>
</ref>
<ref id="bibr73-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Weinberger</surname><given-names>DR</given-names></name>
<name><surname>Gallhofer</surname><given-names>B</given-names></name>
</person-group> (<year>1997</year>) <article-title>Cognitive function in schizophrenia</article-title>. <source>Int Clin Psychopharmacol</source> <volume>12</volume>(<supplement>Suppl. 4</supplement>): <fpage>s29</fpage>-<lpage>s36</lpage>).</citation>
</ref>
<ref id="bibr74-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Willhite</surname><given-names>R</given-names></name>
<name><surname>Niendam</surname><given-names>T</given-names></name>
<name><surname>Bearden</surname><given-names>C</given-names></name><etal/>
</person-group> (<year>2008</year>) <article-title>Gender differences in symptoms, functioning and social support in patients at ultra-high risk for developing a psychotic disorder</article-title>. <source>Schizophr Res</source> <volume>104</volume>: <fpage>237</fpage>–<lpage>245</lpage>.</citation>
</ref>
<ref id="bibr75-0269881113477746">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wykes</surname><given-names>T</given-names></name>
<name><surname>Huddy</surname><given-names>V</given-names></name>
<name><surname>Cellarf</surname><given-names>C</given-names></name><etal/>
</person-group> (<year>2011</year>) <article-title>A meta-analysis of cognitive remediation for schizophrenia: Methodology and effect sizes</article-title>. <source>Am J Psychiatry</source> <volume>168</volume>: <fpage>472</fpage>–<lpage>485</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>